{"id":47,"date":"2023-12-19T12:08:08","date_gmt":"2023-12-19T12:08:08","guid":{"rendered":"https:\/\/ctebiologics.com\/?page_id=47"},"modified":"2025-11-03T00:51:13","modified_gmt":"2025-11-03T00:51:13","slug":"patent","status":"publish","type":"page","link":"https:\/\/ctebiologics.com\/index.php\/patent\/","title":{"rendered":"Patent"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; background_image=&#8221;https:\/\/ctebiologics.com\/wp-content\/uploads\/2023\/05\/header.png&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1 style=\"text-align: center;\"><strong><span style=\"color: #ffffff;\">CTE Biologics, Inc.<\/span><\/strong><\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-66px|||||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p>U.S. Patent No.: 9,803,176 titled as: Methods And Compositions For The Clinical Derivation Of An Allogenic Cell And Therapeutic Uses.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CTE Biologics, Inc.U.S. Patent No.: 9,803,176 titled as: Methods And Compositions For The Clinical Derivation Of An Allogenic Cell And Therapeutic Uses.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-47","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/ctebiologics.com\/index.php\/wp-json\/wp\/v2\/pages\/47","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ctebiologics.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ctebiologics.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ctebiologics.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ctebiologics.com\/index.php\/wp-json\/wp\/v2\/comments?post=47"}],"version-history":[{"count":4,"href":"https:\/\/ctebiologics.com\/index.php\/wp-json\/wp\/v2\/pages\/47\/revisions"}],"predecessor-version":[{"id":70,"href":"https:\/\/ctebiologics.com\/index.php\/wp-json\/wp\/v2\/pages\/47\/revisions\/70"}],"wp:attachment":[{"href":"https:\/\/ctebiologics.com\/index.php\/wp-json\/wp\/v2\/media?parent=47"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}